Bouveret syndrome secondary to a cholecystoduodenal fistula in a patient with locally advanced cholangiocarcinoma
DOI:
https://doi.org/10.18203/2349-2902.isj20260851Keywords:
Bouveret syndrome, Gallstone ileus, Cholangiocarcinoma, Cholecystoduodenal fistula, SurgeryAbstract
Bouveret syndrome is a rare form of gallstone ileus characterized by gastric outlet obstruction caused by the impaction of a large gallstone that migrates through a biliary-enteric fistula. Its occurrence in patients with active biliary malignancy is exceptionally uncommon and poses significant diagnostic and therapeutic challenges. We report the case of a 63-year-old woman with locally advanced, unresectable cholangiocarcinoma who presented with acute abdominal pain, hemodynamic instability, and severe metabolic derangement during first-line systemic therapy. Computed tomography revealed a contained gallbladder perforation with a cholecystoduodenal fistula and a large gallstone impacted in the duodenal bulb, causing secondary gastric dilatation consistent with Bouveret syndrome. Due to clinical deterioration and unfavorable local inflammatory conditions, surgical management was selected. Exploratory laparotomy was performed, and the stone was mobilized retrogradely into the stomach, followed by anterior gastrotomy and successful extraction. The management of Bouveret syndrome remains controversial, particularly in patients with advanced malignancy, as endoscopic treatment has limited success in cases involving large stones or severe inflammation. In this patient, stone size, local anatomy, and oncologic status justified a palliative surgical approach focused on symptom relief and damage control. Bouveret syndrome in the setting of advanced cholangiocarcinoma is rare and associated with poor prognosis; however, individualized, multidisciplinary decision-making is essential, and surgical intervention remains a valid option in unstable patients or when endoscopic management is not feasible.
Metrics
References
Nickel F, Müller-Eschner MM, Chu J, von Tengg-Kobligk H, Müller-Stich BP. Bouveret’s syndrome: presentation of two cases with review of the literature and development of a surgical treatment strategy. BMC Surg. 2013;13(1):33. DOI: https://doi.org/10.1186/1471-2482-13-33
Mavroeidis VK, Matthioudakis DI, Economou NK, Karanikas ID. Bouveret syndrome-the rarest variant of gallstone ileus: a case report and literature review. Case Rep Surg. 2013;2013:839370. DOI: https://doi.org/10.1155/2013/839370
Doycheva I, Limaye A, Suman A, Forsmark CE, Sultan S. Bouveret’s syndrome: case report and review of the literature. Gastroenterol Res Pract. 2009;2009:914951. DOI: https://doi.org/10.1155/2009/914951
Singh G, Merali N, Shirol S, Drymousis P, Singh S, Veeramootoo D. A case report and review of the literature of Bouveret syndrome. Ann R Coll Surg Engl. 2020;102(1):e15-9. DOI: https://doi.org/10.1308/rcsann.2019.0161
Sharma D, Jakhetia A, Agarwal L, Baruah D, Rohtagi A, Kumar A. Carcinoma gall bladder with Bouveret’s syndrome: A rare cause of gastric outlet obstruction. Indian J Surg. 2010;72(4):350-1. DOI: https://doi.org/10.1007/s12262-010-0145-x
Cianci P. Cholecystoduodenocolic fistula by gallbladder carcinoma that presenting as Bouveret’s syndrome: Case report and review of the literature. Int J Gastroenterol Disord Ther. 2014;1:1. DOI: https://doi.org/10.15344/2393-8498/2014/103
DeOliveira ML, Cunningham SC, Cameron JL, Kamangar F, Winter JM, Lillemoe KD, et al. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution: Thirty-one-year experience with 564 patients at a single institution. Ann Surg. 2007;245(5):755-62. DOI: https://doi.org/10.1097/01.sla.0000251366.62632.d3
Angelico R, Sensi B, Parente A, Siragusa L, Gazia C, Tisone G, et al. Vascular involvements in cholangiocarcinoma: Tips and tricks. Cancers (Basel). 2021;13(15):3735. DOI: https://doi.org/10.3390/cancers13153735
Bridgewater J, Galle PR, Khan SA, Llovet JM, Park J-W, Patel T, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol. 2014;60(6):1268-89. DOI: https://doi.org/10.1016/j.jhep.2014.01.021
Date RS, Thrumurthy SG, Whiteside S, Umer MA, Pursnani KG, Ward JB, et al. Gallbladder perforation: case series and systematic review. Int J Surg. 2012;10(2):63-8. DOI: https://doi.org/10.1016/j.ijsu.2011.12.004
Oh D-Y, Ruth He A, Qin S, Chen L-T, Okusaka T, Vogel A, et al. Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer. NEJM Evid. 2022;1(8):EVIDoa2200015. DOI: https://doi.org/10.1056/EVIDoa2200015
Kelley RK, Ueno M, Yoo C, Finn RS, Furuse J, Ren Z, et al. Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2023;401(10391):1853-65. DOI: https://doi.org/10.1016/S0140-6736(23)00727-4
Ong J, Swift C, Stokell BG, Ong S, Lucarelli P, Shankar A, et al. Bouveret syndrome: A systematic review of endoscopic therapy and a novel predictive tool to aid in management. J Clin Gastroenterol. 2020;54(9):758-68. DOI: https://doi.org/10.1097/MCG.0000000000001221
Costi R, Randone B, Violi V, Scatton O, Sarli L, Soubrane O, et al. Cholecystocolonic fistula: facts and myths. A review of the 231 published cases. J Hepatobiliary Pancreat Surg. 2009;16(1):8-18. DOI: https://doi.org/10.1007/s00534-008-0014-1
Patchipala N, Guyn C, Guerrero V. Case report: open surgical management of Bouveret syndrome. J Surg Case Rep. 2025;2025(4):rjae809. DOI: https://doi.org/10.1093/jscr/rjae809